{
    "success": true,
    "data": {
        "id": 1577489,
        "msgid": "bpoms-who-listed-authority-status-boosts-domestic-pharmaceutical-sales-1772280022",
        "date": "2026-02-28 18:10:16",
        "title": "BPOM's WHO Listed Authority Status Boosts Domestic Pharmaceutical Sales",
        "author": "",
        "source": "CNBC",
        "tags": "",
        "topic": "Regulation",
        "summary": "Indonesia's pharmaceutical regulator BPOM has achieved WHO Listed Authority (WLA) status, a significant development that is opening new export opportunities for domestic drug manufacturers. PT Etana Biotechnologies Indonesia, among other local producers, reports heightened confidence and competitive potential in global markets following BPOM's accreditation, which brings Indonesian pharmaceuticals to parity with international standards.",
        "content": "<p>Jakarta \u2014 PT Etana Biotechnologies Indonesia has praised the\nachievement of Indonesia\u2019s pharmaceutical regulator, the Food and Drug\nSupervisory Agency (BPOM), in obtaining WHO Listed Authority (WLA)\nstatus from the World Health Organization. This milestone is expected to\nsignificantly impact the prospects for domestic pharmaceutical\nproducts.<\/p>\n<p>Andreas Donny Prakarsa, Director of Corporate Relations at PT Etana\nBiotechnologies Indonesia, stated that the WLA status obtained by BPOM\nis far more than symbolic; it directly impacts the domestic\npharmaceutical industry. Several countries are now reaching out to\nIndonesian pharmaceutical producers to explore export opportunities for\nnational medicines.<\/p>\n<p>He cited his own company\u2019s experience. As a firm staffed\npredominantly by young employees, Etana was initially uncertain whether\nIndonesian pharmaceuticals could compete in international markets.\nHowever, following BPOM\u2019s achievement of WLA status, Etana\u2019s confidence\nhas increased significantly, as the company\u2019s products now have\npotential for global market penetration.<\/p>\n<p>\u201cOur production teams and staff have also gained confidence. Once\nwe\u2019ve been inspected by BPOM and registered through BPOM, we realised\nthat our standards are equivalent to those in America and Europe. This\nsignificantly boosts the confidence of our young staff,\u201d he said at a\nHealth Forum discussing \u201cBPOM Achieves WLA Status: What Benefits Does It\nBring to Business Operators?\u201d on Friday, 27 February 2026.<\/p>\n<p>He added that BPOM will conduct regular inspections of Etana\u2019s\npharmaceutical products, followed by evaluations at both pre-market and\npost-market stages. This has made Etana more confident in its\npharmaceutical products and company data.<\/p>\n<p>With BPOM\u2019s WLA status, Etana is now prepared to compete at the\nglobal level. Furthermore, Etana possesses valuable human resources\npredominantly composed of young professionals, many of whom are alumni\nof foreign universities who have returned to Indonesia.<\/p>\n<p>\u201cAs an Indonesian nation, with BPOM and WLA status, we truly should\nnot feel inferior anymore. We should be equal with developed nations in\nthe world,\u201d he concluded.<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/bpoms-who-listed-authority-status-boosts-domestic-pharmaceutical-sales-1772280022",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}